Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.21 HKD | +1.68% | +3.42% | +15.24% |
03-25 | Dawnrays' 2023 Profit Falls 9% on Lower Revenue | MT |
03-22 | Dawnrays Pharmaceutical Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 1,143
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Finished Drugs
88.8
%
| 1,322 | 89.0 % | 1,129 | 88.8 % | -14.63% |
Intermediates and Bulk Medicines
11.2
%
| 163 | 11.0 % | 143 | 11.2 % | -12.43% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
98.5
%
| 1,417 | 95.4 % | 1,254 | 98.5 % | -11.55% |
Other Countries
1.5
%
| 69 | 4.6 % | 18 | 1.5 % | -73.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wei Xian Wu
CEO | Chief Executive Officer | 55 | 15/02/22 |
Yi jun Wu
DFI | Director of Finance/CFO | 59 | 30/11/02 |
Kei Ling Li
CHM | Chairman | 75 | 30/09/02 |
Michelle Li
IRC | Investor Relations Contact | - | - |
Kit Ling Pang
SEC | Corporate Secretary | 58 | 30/06/03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kei Ling Li
CHM | Chairman | 75 | 30/09/02 |
Yung Lai Hung
BRD | Director/Board Member | 79 | 30/09/02 |
Hong Man Leung
BRD | Director/Board Member | 49 | 31/10/05 |
Hao Xi Ede
BRD | Director/Board Member | 65 | 14/06/15 |
Tung Sing Lo
BRD | Director/Board Member | 55 | - |
Ming Yee Lam
BRD | Director/Board Member | 56 | 24/05/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,500,421,000 | 599,729,000 ( 39.97 %) | 0 | 39.97 % |
Company contact information
Dawnrays Pharmaceutical Holdings Ltd.
Units 3001–02, 30/F, CNT Tower 338 Hennessy Road
, Hong Kong
+
http://www.dawnrays.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+15.24% | 232M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 2348 Stock
- Company Dawnrays Pharmaceutical (Holdings) Limited